• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病合并球孢子菌病感染

Concurrent Coccidioidomycosis and Infection in Chronic Obstructive Pulmonary Disease.

作者信息

Kattamuri Lakshmi, Zambrano Angelica, Duvvuru Sparsha Reddy, Sharma Kunal, Deoker Abhizith

机构信息

Texas Tech University Health Sciences Center El Paso, USA.

Paul L. Foster School of Medicine, El Paso, TX, USA.

出版信息

J Investig Med High Impact Case Rep. 2025 Jan-Dec;13:23247096251334229. doi: 10.1177/23247096251334229. Epub 2025 Apr 28.

DOI:10.1177/23247096251334229
PMID:40292938
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12038191/
Abstract

Coccidioidomycosis, endemic in the southwestern United States, can lead to severe pulmonary complications, particularly in chronic obstructive pulmonary disease (COPD) patients with poor lung reserves. has a predisposition for structurally damaged lungs, commonly causing difficult-to-treat bronchiectasis and cavitary lesions. We present the case of a 58-year-old patient with advanced COPD and a remote history of pulmonary coccidioidomycosis diagnosed 30 years earlier, who was found to have sputum and radiographic evidence of cavitary lung disease 4 years prior to admission, but was lost to follow-up. The current presentation is attributed to the progression of untreated infection and reactivation of latent infection. Despite the initiation of antifungal and antibiotic therapy, the subsequent course was complicated by the development of bronchopleural fistula and worsening respiratory failure, leading to an unfavorable outcome. This case highlights the diagnostic challenges associated with overlapping clinical and radiologic features of concurrent infections and devastating outcomes in patients with COPD. Prompt diagnostic testing and prolonged comprehensive therapy are of paramount importance in managing such complex infections.

摘要

球孢子菌病在美国西南部为地方性疾病,可导致严重的肺部并发症,尤其是在肺储备功能差的慢性阻塞性肺疾病(COPD)患者中。它易发生于结构受损的肺部,常导致难以治疗的支气管扩张和空洞性病变。我们报告一例58岁的患者,患有晚期COPD,30年前曾诊断为肺球孢子菌病,入院前4年发现有痰液及影像学证据显示有空洞性肺病,但失访。目前的表现归因于未治疗感染的进展和潜伏感染的重新激活。尽管开始了抗真菌和抗生素治疗,但随后的病程因支气管胸膜瘘的发展和呼吸衰竭的恶化而复杂化,导致了不良结局。该病例突出了COPD患者并发感染的临床和放射学特征重叠所带来的诊断挑战以及灾难性后果。及时的诊断检测和长期的综合治疗对于管理此类复杂感染至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba3/12038191/e90354450a61/10.1177_23247096251334229-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba3/12038191/2455a572af23/10.1177_23247096251334229-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba3/12038191/31a886f27016/10.1177_23247096251334229-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba3/12038191/e90354450a61/10.1177_23247096251334229-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba3/12038191/2455a572af23/10.1177_23247096251334229-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba3/12038191/31a886f27016/10.1177_23247096251334229-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aba3/12038191/e90354450a61/10.1177_23247096251334229-fig3.jpg

相似文献

1
Concurrent Coccidioidomycosis and Infection in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病合并球孢子菌病感染
J Investig Med High Impact Case Rep. 2025 Jan-Dec;13:23247096251334229. doi: 10.1177/23247096251334229. Epub 2025 Apr 28.
2
Microscopic polyangiitis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report.分枝杆菌脓肿分枝杆菌继发显微镜下多血管炎支气管扩张症 1 例报告
BMC Pulm Med. 2018 Nov 19;18(1):170. doi: 10.1186/s12890-018-0732-3.
3
Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease.非空洞性结节状支气管扩张性非结核分枝杆菌性肺病的长期自然病史。
Respir Med. 2019 May;151:1-7. doi: 10.1016/j.rmed.2019.03.014. Epub 2019 Mar 26.
4
[Chinese expert consensus on diagnosis and treatment of non-tuberculous mycobacterial pulmonary disease complicated with bronchiectasis].《非结核分枝杆菌肺病合并支气管扩张症诊断与治疗中国专家共识》
Zhonghua Jie He He Hu Xi Za Zhi. 2025 Feb 12;48(2):101-115. doi: 10.3760/cma.j.cn112147-20240808-00471.
5
Outcomes of pulmonary infection.肺部感染的结果。
Int J Mycobacteriol. 2020 Jan-Mar;9(1):48-52. doi: 10.4103/ijmy.ijmy_3_20.
6
Risk factors for microbiologic failure among Taiwanese adults with Mycobacterium abscessus complex pulmonary disease.台湾成年人分枝杆菌脓肿复合体肺病患者微生物学失败的危险因素。
J Microbiol Immunol Infect. 2015 Aug;48(4):437-45. doi: 10.1016/j.jmii.2014.08.005. Epub 2014 Oct 22.
7
Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease.含吸入性阿米卡星的多药方案治疗脓肿分枝杆菌肺病的结局。
Chest. 2021 Aug;160(2):436-445. doi: 10.1016/j.chest.2021.02.025. Epub 2021 Feb 20.
8
Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease.大环内酯类敏感脓肿分枝杆菌肺病的治疗结果
Diagn Microbiol Infect Dis. 2018 Apr;90(4):293-295. doi: 10.1016/j.diagmicrobio.2017.12.008. Epub 2017 Dec 16.
9
Mycobacterium abscessus pneumonia in a South Pacific islander.一名南太平洋岛民患脓肿分枝杆菌肺炎。
J Microbiol Immunol Infect. 2017 Jun;50(3):393-394. doi: 10.1016/j.jmii.2015.01.008. Epub 2015 Jan 30.
10
18 Cases of pulmonary Mycobacterium abscessus: Clinical difference depending on the presence or absence of Mycobacterium avium complex.18例肺脓肿分枝杆菌感染:根据鸟分枝杆菌复合群的有无存在的临床差异
J Infect Chemother. 2016 Sep;22(9):622-8. doi: 10.1016/j.jiac.2016.06.009. Epub 2016 Jul 16.

本文引用的文献

1
Clinical Characteristics and Mortality Risks Among Patients With Culture-Proven Coccidioidomycosis Who Are Critically Ill: A Multicenter Study in an Endemic Region.确诊为球孢子菌病的重症患者的临床特征及死亡风险:流行地区的一项多中心研究
Open Forum Infect Dis. 2024 Aug 7;11(8):ofae454. doi: 10.1093/ofid/ofae454. eCollection 2024 Aug.
2
Coccidioidomycosis-Related Hospital Visits, Texas, USA, 2016-2021.2016-2021 年美国德克萨斯州与球孢子菌病相关的医院就诊情况。
Emerg Infect Dis. 2024 May;30(5):882-889. doi: 10.3201/eid3005.231624.
3
Outcomes with severe pulmonary coccidioidomycosis and respiratory failure in the United States.
美国严重肺球孢子菌病和呼吸衰竭的预后情况。
J Assoc Med Microbiol Infect Dis Can. 2023 Mar 1;8(1):40-48. doi: 10.3138/jammi-2022-0028. eCollection 2023 Mar.
4
Mycobacterium abscessus infection results in decrease of oxidative metabolism of lung airways cells and relaxation of the epithelial mucosal tight junctions.脓肿分枝杆菌感染导致肺气道细胞氧化代谢降低以及上皮黏膜紧密连接松弛。
Tuberculosis (Edinb). 2023 Jan;138:102303. doi: 10.1016/j.tube.2023.102303. Epub 2023 Jan 10.
5
Thoracic Endemic Fungi in the United States: Importance of Patient Location.美国胸内地方性真菌:患者位置的重要性。
Radiographics. 2021 Mar-Apr;41(2):380-398. doi: 10.1148/rg.2021200071. Epub 2021 Feb 5.
6
Sociodemographic factors associated with patients hospitalised for coccidioidomycosis in California and Arizona, State Inpatient Database 2005-2011.与加利福尼亚州和亚利桑那州因球孢子菌病住院的患者相关的社会人口学因素,2005-2011 年州住院患者数据库。
Epidemiol Infect. 2020 Nov 20;149:e127. doi: 10.1017/S0950268820002836.
7
Summary for Clinicians: 2020 Clinical Practice Guideline Summary for the Treatment of Nontuberculous Mycobacterial Pulmonary Disease.临床医生摘要:2020年非结核分枝杆菌肺病治疗临床实践指南摘要。
Ann Am Thorac Soc. 2020 Sep;17(9):1033-1039. doi: 10.1513/AnnalsATS.202003-222CME.
8
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.非结核分枝杆菌肺病治疗:美国胸科学会/欧洲呼吸学会/欧洲临床微生物学和传染病学会/美国感染病学会临床实践指南
Clin Infect Dis. 2020 Aug 14;71(4):e1-e36. doi: 10.1093/cid/ciaa241.
9
Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus.非结核分枝杆菌与脓肿分枝杆菌的崛起。
Nat Rev Microbiol. 2020 Jul;18(7):392-407. doi: 10.1038/s41579-020-0331-1. Epub 2020 Feb 21.
10
Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study.1445例非结核分枝杆菌肺病患者长期死亡率的预后因素:一项15年随访研究
Eur Respir J. 2020 Jan 2;55(1). doi: 10.1183/13993003.00798-2019. Print 2020 Jan.